Naloxona Accord (Naloxone)

Naloxone, the active ingredient in Naloxona Accord, is an opioid antagonist presented as an injectable solution for intravenous use. It rapidly reverses the pharmacologic effects of opioid overdose in emergency and clinical settings.

GNH USA supplies Naloxona Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for import and distribution. Products are shipped with appropriate temperature control and traceability to ensure safety throughout the supply chain.

Naloxone is an opioid antagonist used to counteract opioid toxicity by restoring normal physiological function.

- Opioid overdose: rapidly restores breathing and consciousness in patients with life‑threatening opioid intoxication. - Opioid‑induced respiratory depression: reverses depressed respiratory drive caused by opioid analgesics. - Opioid‑induced sedation: reestablishes alertness in individuals experiencing excessive sedation from opioid use.

Naloxone may be associated with a range of adverse reactions, most of which are related to the abrupt reversal of opioid effects.

Common Side Effects: - Nausea - Vomiting - Sweating - Tachycardia

Serious or Rare Side Effects: - Pulmonary edema - Seizures - Anaphylaxis

When using Naloxona Accord, several safety considerations should be observed.

- Assess airway and breathing: ensure the patient can maintain a patent airway before administration. - Monitor cardiovascular status: watch for rapid changes in blood pressure and heart rate. - Consider opioid dependence: abrupt reversal may precipitate acute withdrawal symptoms. - Use with caution in patients with cardiovascular disease: risk of hypertension or arrhythmia. - Store below 25°C: keep in the original packaging, protect from moisture and light.

Naloxona Accord can interact with other medications; awareness of these interactions helps maintain patient safety.

Major Interactions (Avoid): - Opioid agonists: may cause sudden opioid withdrawal and severe agitation. - Monoamine oxidase inhibitors: combined use can lead to hypertensive crisis. - Tricyclic antidepressants: increase risk of seizures when naloxone is administered.

Moderate Interactions (Monitor Closely): - Benzodiazepines: may mask signs of opioid withdrawal. - Alcohol: additive central nervous system depression may persist after naloxone.